Dysregulated Ribosome Biogenesis in Colorectal Cancer: The Emerging Role of Fibrillarin

whole, these findings demonstrate the various biological roles of FBL, which go far beyond ribosome biogenesis and include development, aging, viral pathogenesis, autoimmunity, and cancer.4 Aberrant rRNA 2'-O-methylation patterns, together with transcriptional and genetic alterations in FBL, have increasingly been recognized as important regulators of cancer development and progression (Fig. 1).6 Emerging evidence indicates that rRNA 2'-O-methylation is not a constitutive structural mark but rather a dynamic epitranscriptomic modification.The cell's repertoire of proteins is shaped by these methylation events, which also affect ribosome assembly, structural stability, translational fidelity, and codon decoding efficiency.Functionally distinct ribosomes known as oncoribosomes can be produced by aberrant FBL-mediated rRNA methylation.These ribosomes preferentially translate transcripts related to cellular stress responses, metabolic adaptation, proliferation, and survival.This emerging concept helps explain how dysregulated FBL activity contributes to colorectal cancer (CRC) progression and offers a mechanistic framework connecting modified ribosome biogenesis with translational reprogramming.CRC is characterized by prominent nucleolar enlargement and increased protein synthetic demand, making dysregulated ribosome biogenesis a particularly relevant hallmark of disease progression.The enlarged and dysregulated nucleoli are hallmarks of cancer cells with increased ribosome biogenesis and high metabolic demands.FBL is a crucial regulator of ribosome biogenesis and a major contributor to tumorigenesis in several cancers, including CRC. 7 Aberrant FBL expression promotes the selective translation of oncogenic transcripts by altering ribosome structure, translational fidelity, and rRNA

Authors

Institutions

Publication Details

Journal
Journal of Postgraduate Medicine Education and Research
Published
2026-11-18
DOI
https://doi.org/10.5005/jp-journals-10028-1819
Primary Topic
RNA modifications and cancer
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Dysregulated Ribosome Biogenesis in Colorectal Cancer: The Emerging Role of Fibrillarin

Yashwant Kumar, Alka Bhatia
5 links
Journal of Postgraduate Medicine Education and Research
RNA modifications and cancer
article

Dysregulated Ribosome Biogenesis in Colorectal Cancer: The Emerging Role of Fibrillarin

Yashwant Kumar, Alka Bhatia
article en

Abstract

whole, these findings demonstrate the various biological roles of FBL, which go far beyond ribosome biogenesis and include development, aging, viral pathogenesis, autoimmunity, and cancer.4 Aberrant rRNA 2'-O-methylation patterns, together with transcriptional and genetic alterations in FBL, have increasingly been recognized as important regulators of cancer development and progression (Fig. 1).6 Emerging evidence indicates that rRNA 2'-O-methylation is not a constitutive structural mark but rather a dynamic epitranscriptomic modification.The cell's repertoire of proteins is shaped by these methylation events, which also affect ribosome assembly, structural stability, translational fidelity, and codon decoding efficiency.Functionally distinct ribosomes known as oncoribosomes can be produced by aberrant FBL-mediated rRNA methylation.These ribosomes preferentially translate transcripts related to cellular stress responses, metabolic adaptation, proliferation, and survival.This emerging concept helps explain how dysregulated FBL activity contributes to colorectal cancer (CRC) progression and offers a mechanistic framework connecting modified ribosome biogenesis with translational reprogramming.CRC is characterized by prominent nucleolar enlargement and increased protein synthetic demand, making dysregulated ribosome biogenesis a particularly relevant hallmark of disease progression.The enlarged and dysregulated nucleoli are hallmarks of cancer cells with increased ribosome biogenesis and high metabolic demands.FBL is a crucial regulator of ribosome biogenesis and a major contributor to tumorigenesis in several cancers, including CRC. 7 Aberrant FBL expression promotes the selective translation of oncogenic transcripts by altering ribosome structure, translational fidelity, and rRNA

Journal of Postgraduate Medicine Education and ResearchVol. 61(1)
Post Graduate Institute of Medical Education and Research (IN)
Good health and well-being
RNA modifications and cancer
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon